Using Drug Claims Data to Assess the Relationship of Medication Adherence With Hospitalization and Costs
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wyatt RJ, Henter I: An economic evaluation of manic-depressive illness, 1991. Social and Psychiatric Epidemiology 30:213-219, 1995
Wyatt RJ, Henter I, Leary MC, et al: An economic evaluation of schizophrenia, 1991. Social Psychiatry and Psychiatric Epidemiology 30:196-205, 1995
Frank RG, Brookmeyer R: Managed mental health care and patterns of inpatient utilization for treatment of affective disorders. Social Psychiatry and Psychiatric Epidemiology 30:220-223, 1995
Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council. American Journal of Psychiatry 150:1447-1465, 1993
Haywood TW, Kravitz HM, Grossman LS, et al: Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry 152:856-861, 1995
Green JH: Frequent rehospitalization and noncompliance with treatment. Hospital and Community Psychiatry 39:963-966, 1988
Caton CLM, Koh SP, Fleiss JL, et al: Rehospitalization in chronic schizophrenia. Journal of Nervous and Mental Disease 173:139-148, 1985
Sullivan G, Wells KB, Morgenstern H, et al: Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. American Journal of Psychiatry 152:1749-1756, 1995
McEvoy JP, Howe AC, Hogarty GE: Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients. Journal of Nervous and Mental Disease 172:412-416, 1984
Johnson RE, McFarland BH: Lithium use and discontinuation in a health maintenance organization. American Journal of Psychiatry 153:993-1000, 1996
Cramer JA, Rosenheck R: Compliance with medication regimens for mental and physical disorders. Psychiatric Services 49:196-201, 1998
Dickey B, Normand ST, Norton EC, et al: Managing the care of schizophrenia: lessons from a 4-year Massachusetts Medicaid study. Archives of General Psychiatry 53:945-952, 1996
Strom B, Carson JL: Use of automated databases for pharmacoepidemiology research. Epidemiologic Reviews 12:87-107, 1990
Steiner JF, Koepsell TD, Fihn SD, et al: A general method of compliance assessment using centralized pharmacy records. Medical Care 26:814-823, 1988
Ray WA, Griffin MR: Use of Medicaid data for pharmacoepidemiology. American Journal of Epidemiology 129:837-849, 1989
Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al: Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine 331:650-655, 1994
McCombs JS, Nichol MB, Stimmel GL, et al: The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. Journal of Clinical Psychiatry 51:60-71, 1990
Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23:637-651, 1997
Kent S, Yellowlees P: Psychiatric and social reasons for frequent rehospitalization. Hospital and Community Psychiatry 45:347-349, 1994
Glazer WM, Ereshefsky L: A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients. Journal of Clinical Psychiatry 57:337-345, 1996
Hollingsworth EJ, Sweeney JK: Mental health expenditures for services for people with severe mental illnesses. Psychiatric Services 48:485-490, 1997
Shireman TI, Svarstad BL, Sweeney JK: Validity of claims for long-acting injectable medications. Journal of Pharmacoepidemiology 7:41-55, 1999
Endicott J, Spitzer RL, Fleiss JL, et al: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33:766-771, 1976